Australia makes fundamental advances in understanding T cell immunity

Australia's Monash University researchers have provided a fundamental advance regarding how T cells become activated whe...

June 4, 2021 | Friday | News
Vela Diagnostics, NCCS to refine novel cancer therapy in Singapore

Vela Diagnostics has announced a collaboration with the National Cancer Centre of Singapore (NCCS) to develop ...

June 4, 2021 | Friday | News
AVATAMED, A*STAR open joint lab for precision oncology services in Singapore

AVATAMED, a precision medicine service company based in Singapore, has announced the setting up of a joint lab with...

June 1, 2021 | Tuesday | News
China designs biomimetic nanosheet for cancer therapy and imaging

A research team from the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic Unive...

June 1, 2021 | Tuesday | News
Japan takes step forward towards treating hereditary deafness

Researchers at Juntendo University in Japan report in the journal Human Molecular Genetics that a stem-cell te...

May 31, 2021 | Monday | News
Australia develops world-first multiple sclerosis global image database

A world-first global MS image database has been launched in Australia complementing MSBase, the largest clinical MS pati...

May 31, 2021 | Monday | News
Singapore discovers way to predict chemotherapy resistance

Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resist...

May 31, 2021 | Monday | News
Singapore develops new biomaterial to aid in bone repair

A research team at the Nanyang Technological University (NTU) in Singapore has developed a new biomaterial to ...

May 28, 2021 | Friday | News
China develops new therapeutic direction for Huntington’s disease

Professor Ho Yin Edwin Chan from the School of Life Sciences of The Chinese University of Hong Kong (CUHK), in coll...

May 27, 2021 | Thursday | News
Scientists explore use of violet light to stop myopia progression

An international team of researchers has taken an important step toward understanding a powerful potential treatment for...

May 26, 2021 | Wednesday | News
Australia's Microba Life Sciences partners with Illumina to accelerate microbiome research

Illumina, Inc., the global leader in DNA sequencing and array-based technologies, has announced that it has united with ...

May 25, 2021 | Tuesday | News
Hong Kong's Genome Project to implement first large-scale sequencing initiative

UK-based startup Lifebit Biotech Ltd has announced that it has been awarded a four-year contract by Hong Kong Genome Ins...

May 25, 2021 | Tuesday | News
Singapore opens new centre to advance regenerative medicine

The SingHealth Duke-NUS Academic Medical Centre (AMC) has announced the launch of a research institute and disease centr...

May 25, 2021 | Tuesday | News
China develops novel targeted therapy for breast cancer

A group of researchers from Hong Kong Baptist University (HKBU), in collaboration with Cornell University in the US, has...

May 21, 2021 | Friday | News
Singapore proposes new holistic way of understanding infections

An international research team led by NTU Singapore has proposed a new holistic way of understanding infection...

May 21, 2021 | Friday | News
Singapore creates intelligent material for delivering drugs within body

Researchers from the Centre for Advanced 2D Materials (CA2DM) at the National University of Singapore (NUS) ha...

May 13, 2021 | Thursday | News
ERS Genomics and GenScript sign CRISPR/Cas9 license agreement

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...

May 12, 2021 | Wednesday | News
Korean firm MDimune focuses on novel targeted extracellular vesicle-based therapeutics

Navigo Proteins, a protein engineering biotech company generating scaffold protein-based affinity ligands, and MDimune, ...

May 12, 2021 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls